Nasdaq

Talem Health Analytics’ Injury Causation Integration for ClaimCenter Now Available in Guidewire Marketplace

Talem Health Analytics’ Ready for Guidewire accelerator helps insurers mitigate bodily injury claims fraud, while improving customer experience Talem provides auto insurers with early insights of ...
Nasdaq

Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre

Multi-target research collaboration leverages ImmunoPrecise’s powerful antibody discovery technologies with the long-standing expertise of Pierre Fabre in immuno-oncology ImmunoPrecise is an ...
Business Wire

IPA’s Subsidiary Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs

VICTORIA, British Columbia--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), today announced that its ...
PharmiWeb

ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio

VICTORIA, British Columbia & SANTIAGO DE COMPOSTELA, Spain--(BUSINESS WIRE)--$IPA #AI--Immunoprecise Antibodies Ltd. (NASDAQ: IPA) (“Immunoprecise” or “IPA ...
Newswire

ImmunoPrecise's Wholly Owned Talem Therapeutics Announces the Creation of its Scientific Committee

VICTORIA, Aug. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB PINK: IPATF) announces the launch of its High Value Target Scientific Committee which ...
Business Wire

Talem Health Analytics’ Injury Causation Integration for ClaimCenter Now Available in Guidewire Marketplace

SYDNEY, Nova Scotia & SAN MATEO, Calif.--(BUSINESS WIRE)--Talem Health Analytics, Inc. (Talem), a leading provider of bodily injury causation solutions and Guidewire PartnerConnect Solution partner, ...